The TSC1-2 tumor suppressor controls insulin-PI3K signaling through the regulation of IRS proteins - Evidence review

In mouse cells, loss of TSC1-2 keeps mTOR-S6K overactive and lowers IRS proteins, blunting insulin and IGF-1 signaling. Preclinical evidence.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24335042
Primary Topic
PI3K/AKT/mTOR signaling in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The TSC1-2 tumor suppressor controls insulin-PI3K signaling through the regulation of IRS proteins - Evidence review

Melania Mondini
Zenodo (CERN European Organization for Nuclear Research)
PI3K/AKT/mTOR signaling in cancer
article

The TSC1-2 tumor suppressor controls insulin-PI3K signaling through the regulation of IRS proteins - Evidence review

Melania Mondini
article en

Abstract

In mouse cells, loss of TSC1-2 keeps mTOR-S6K overactive and lowers IRS proteins, blunting insulin and IGF-1 signaling. Preclinical evidence.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
PI3K/AKT/mTOR signaling in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon